2010
Establishment in a small workshop
Pharmaceutical Production License
ISO ISO9001, ISO14001, ISO45001 Certifications
2013
2015
NMPA registration No.:
Hydroxypropyl betadex : F20209990366( (Oral )
Hydroxypropyl betadex : F20180001469 (Injection)
Betadex Sulfobutyl Ether Sodium: F20190000285
U.S. FDA registration No.:
Hydroxypropyl betadex：030167
Betadex Sulfobutyl Ether Sodium：030168
The standard GMP workshop was built, including two production lines of Betadex Sulfobutyl Ether Sodium and hydroxypropyl betadex, covering an area of 3,200 square meters.
2018
2020
New R&D Center and Sales Center completed in Jinan.
Hydroxypropyl Betadex state as Active in NMPA
Methyl beta cyclodextrin approved by China NMPA, CDE NO.: F20210000272
2021
2022
Hydroxypropyl Gamma Cyclodextrin approved by the US FDA, DMF NO.:037142 and approved by China NMPA, CDE NO.: F20220000042
Science and Technology Innovation Center was completed and put into use.
New cosmetics materials successfully developed
BETADEX SULFOBUTYL ETHER SODIUM state as Active in NMPA.
2023
UP TO NOW